Champions Oncology (CSBR) Financial Statements & Analysis

Champions Oncology (CSBR) Income Statement

Champions Oncology reported revenue of $59.42M in fiscal 2026 (fiscal year ended Apr 30, 2026), up 4.4% from $56.94M a year earlier. Champions Oncology posted a net loss of $1.18M, compared with net income of $4.70M a year earlier. Gross margin was 48.0% and operating margin -1.9%. In the most recent quarter, Q1 fiscal 2027 (ended Jul 31, 2026), revenue was $15.23M, up 8.8% from the same quarter a year earlier.

Champions Oncology Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Champions Oncology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Apr 2026	Apr 2025	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017
Revenue & Gross Profit
Revenue	59.43	56.94	50.16	53.87	49.11	41.04	32.12	27.07	20.24	15.41
Cost of Revenue	30.90	28.39	29.40	29.53	23.63	21.45	17.00	14.27	10.55	9.70
Gross Profit	28.53	28.56	20.75	24.34	25.48	19.59	15.12	12.80	9.69	5.71
Operating Expenses
Research & Development	9.08	6.83	9.54	11.55	9.37	7.20	5.85	4.80	4.40	4.29
Selling, General & Administrative	20.47	16.88	18.13	17.24	15.50	12.03	10.86	7.73	6.64	8.22
Operating Expenses	29.67	23.71	28.11	29.59	24.87	19.23	17.04	12.53	11.04	12.52
Operating Income	-1.14	4.85	-7.36	-5.26	0.61	0.37	-1.92	0.27	-1.35	-6.81
Other Income/Expense
Interest Income	0.00	0.00	0.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.00	0.00	-0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	0.21	-0.22	0.05	-0.01	-0.02	0.07	-0.04	-0.04	-0.09	-0.06
Income
Income Before Tax	-0.93	4.63	-7.31	-5.27	0.58	0.44	-1.96	0.23	-1.44	-6.87
Income Tax Expense	0.25	-0.08	-0.03	0.07	0.04	0.08	0.13	0.10	0.03	0.02
Net Income	-1.18	4.70	-7.28	-5.34	0.55	0.36	-2.09	0.13	-1.48	-6.88
Net Income - Continuous Operations	-1.18	4.70	-7.28	-5.34	0.55	0.36	-2.09	0.13	-1.48	-6.88
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-
EBITDA	0.35	6.27	-5.05	-2.83	2.23	1.55	-0.76	0.88	-0.99	-6.64
EBIT	-1.03	4.85	-6.92	-4.45	0.61	0.37	-	-	-	-
Depreciation & Amortization	1.38	1.64	1.87	1.62	1.63	1.18	0.83	0.61	0.36	0.17
Earnings Per Share
Basic EPS	-	-	-1.00	-	-	-	-	-	-	-1.00
Diluted EPS	-	-	-1.00	-	-	-	-	-	-	-1.00
Basic Shares Outstanding	13.83	13.66	13.55	13.54	13.20	13.14	11.84	11.34	10.99	10.68
Diluted Shares Outstanding	13.83	14.27	13.55	13.54	14.16	14.57	11.84	14.10	11.00	10.98

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Champions Oncology Financial Statements

What was Champions Oncology's revenue in fiscal 2026?

Champions Oncology reported revenue of $59.42M in fiscal 2026 (fiscal year ended Apr 30, 2026). That was up 4.4% from $56.94M a year earlier.

Is Champions Oncology profitable?

No. Champions Oncology reported a net loss of $1.18M in fiscal 2026. In fiscal 2025 it earned $4.70M.

What is Champions Oncology's operating margin?

Champions Oncology's operating income was −$1.14M on revenue of $59.42M in fiscal 2026, an operating margin of -1.9%, compared with 8.5% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition